Biosurgical Agents – Market Insights – Japan
Although it will be impacted in the short term by the COVID-19 pandemic, the biosurgical agent market in Japan will grow at a moderate rate through 2029, driven by rising surgical procedure volumes, the introduction of new products, and expanding indications for the existing products.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for Biosurgical Agents in Japan across a 10-year period.
The COVID-19 pandemic will affect the Japanese biosurgical agent market.
Which surgical specialties will be most impacted?
At what pace is the biosurgical agent market expected to recover?
The biosurgical agent market is driven by trends in surgical procedure volumes.
Which specialties are the strongest drivers of the market and why?
How will procedure trends be affected by technological advancements in surgical techniques?
Competitors are expanding their portfolios and investing in clinical trials.
Which companies lead the market and how are they promoting their products?
What strategies are used by smaller players to enter the market and compete with existing products?
Few biosurgical agents are available in the Japanese market.
Which segments have limited products available and what are the unmet needs?
Which segments are growing and what are the potential opportunities for market entry?
Table of contents
- Biosurgical Agents - Market Insights - Japan
- Abstract
- Executive Summary
- COVID-19 Updates
- Market Highlights
- Factors Impacting the Biosurgical Agents Market, by Product Type, Japan
- Biosurgical Agent Market, by Product Type, Japan (USD), 2019u20132029
- Biosurgical Agent Market Landscape, Japan (USD), 2019 and 2029
- Competitive Highlights
- Biosurgical Agents Revenue Market Share Rankings, by Product Type, Japan, 2019
- Companies Mentioned
- Market Developments
- Recent Events in the Biosurgical Agents Market, Japan
- Emerging Products for the Biosurgical Agents Market, Japan
- End-User Insights
- Average Currency Exchange Rates
- Products Covered
- Product Covered, Japan
- COVID-19 Updates
- Key Report Updates
- COVID-19 Analysis
- Market Impact
- COVID-19 Impact Assessment Summary, Biosurgical Agent Market, Japan
- Guidance and Recommendations
- Guidance and Recommendations for Surgical Procedures
- Major Market Forecast Changes and Assumptions
- Biosurgical Agent Market, by Product Type, Japan (USD), 2019u20132029 (Excluding COVID-19 Impact)
- Biosurgical Agent Market, by Product Type, Japan (USD), 2019u20132029 (Including COVID-19 Impact)
- Competitive Impact
- COVID-19 Competitive Factors and Strategies, Biosurgical Agent Market, Japan
- COVID-19 Impact by Competitor, Biosurgical Agents Market, Japan
- Market Impact
- Biosurgical Agent Market
- Market Highlights
- Factors Impacting the Biosurgical Agents Market, by Product Type, Japan
- Biosurgical Agent Market, by Product Type, Japan (USD), 2019u20132029
- Biosurgical Agent Market, by Specialty, Japan (USD), 2019u20132029
- Market Definitions
- Market Forecast Data
- Biosurgical Agent Market, by Product Type, Japan (USD), 2019u20132029
- Biosurgical Agent Market Growth, by Product Type, Japan, 2020u20132029
- Biosurgical Agent Market, by Specialty, Japan (USD), 2019u20132029
- Competitive Highlights
- Market Share Rankings
- Biosurgical Agents Revenue Market Share Rankings, by Product Type, Japan, 2019
- Competitive Factors and Strategies
- Competitive Factors and Strategies, by Product Type, Japan
- Market Developments
- Recent Events in the Biosurgical Agents Market, Japan
- Emerging Products for the Biosurgical Agents Market, Japan
- Market Highlights
- Surgical Hemostat Market
- Market Highlights
- Surgical Hemostat Market, by Material, Japan (USD), 2019u20132029
- Surgical Hemostat Market, by Specialty, Japan (USD), 2019u20132029
- Market Definitions
- Market Forecast Data
- Surgical Hemostat Market, by Material, Japan (USD), 2019u20132029
- Surgical Hemostat Market Growth, by Material, Japan, 2020u20132029
- Surgical Hemostat Market, by Specialty, Japan (USD), 2019u20132029
- Surgical Hemostat Market Growth, by Specialty, Japan, 2019u20132029
- Competitive Highlights
- Market Share Rankings
- Surgical Hemostat Revenue Market Share Rankings, Japan, 2019
- Competitive Factors and Strategies
- Competitive Factors and Strategies, Japan
- Market Highlights
- Internal Tissue Sealant Market
- Market Highlights
- Internal Tissue Sealant Market, by Material, Japan (USD), 2019u20132029
- Internal Tissue Sealant Market, by Specialty, Japan (USD), 2019u20132029
- Market Definitions
- Market Forecast Data
- Internal Tissue Sealant Market, by Material, Japan (USD), 2019u20132029
- Internal Tissue Sealant Market Growth, by Material, Japan, 2020u20132029
- Internal Tissue Sealant Marketu200b, by Specialty, Japan (USD), 2019u20132029
- Internal Tissue Sealant Market Growthu200b, by Specialty, Japan, 2019u20132029
- Competitive Highlights
- Market Share Rankings
- Internal Tissue Sealant Revenue Market Share Rankings, Japan, 2019
- Competitive Factors and Strategies
- Competitive Factors and Strategies, Japan
- Market Highlights
- Adhesion Barrier Market
- Market Highlights
- Adhesion Barrier Market, by Specialty, Japan (USD), 2019u20132029
- Market Definitions
- Market Forecast Data
- Adhesion Barrier Market, by Specialty, Japan (USD), 2019u20132029
- Adhesion Barrier Market Growth, by Specialty, Japan, 2020u20132029
- Competitive Highlights
- Market Share Rankings
- Adhesion Barrier Revenue Market Share Rankings, Japan, 2019
- Competitive Factors and Strategies
- Competitive Factors and Strategies, Japan
- Market Highlights
- Appendix
- Abbreviations
- Bibliography
- Abbreviations
Sumit Jain is a senior analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, focusing on diagnostic imaging capital equipment and healthcare IT markets. Sumit holds a Bachelor’s degree in Pharmacy from the Rajiv Gandhi Technical University, Bhopal, and a Master’s degree in Pharmacoinformatics from the National Institute of Pharmaceutical Education and Research, Mohali.
Dhara Patel is a research associate on the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at DRG (Part of Clarivate), specializing in capital equipment such as infusion systems and healthcare IT markets. Dhara holds a Bachelor’s degree in Pharmaceutical Sciences from the University of Mumbai and a Master’s degree in Medicinal Chemistry from the National Institute of Pharmaceutical Education and Research, Mohali.